I now have comprehensive information. Let me compile the full answer.
Layers of the Cornea
Labeled Diagram
From Kanski's Clinical Ophthalmology (Fig. 7.1) — Anatomy of the Cornea:
Generated diagram for clarity:
The Five Layers of the Cornea
The cornea is ~0.5 mm thick centrally and ~1 mm peripherally. It consists of three cellular layers separated by two acellular membranes:
| Layer | Key Features |
|---|
| 1. Epithelium | Non-keratinized stratified squamous epithelium, ~50 μm thick (~5 cell layers). Cells arranged as: surface squamous cells → wing cells → basal columnar cells resting on basement membrane. Remarkable regenerative capacity (turnover ~7 days). Stem cells reside at the corneoscleral limbus. |
| 2. Bowman's Layer (Anterior Limiting Membrane) | Acellular; superficial condensed layer of the stroma composed of collagen fibres. Cannot regenerate — scarring is permanent once damaged. |
| 3. Stroma | Constitutes ~90% of corneal thickness. Regularly arranged orthogonal collagen lamellae (types I & V) spaced by proteoglycan ground substance (keratan sulphate, chondroitin sulphate) with interspersed keratocytes. Regular spacing is critical for optical transparency. Can scar but cannot fully regenerate. |
| 4. Descemet's Membrane (Posterior Limiting Membrane) | Discrete sheet of collagen fibrils distinct from stromal collagen. Has an anterior banded zone (deposited in utero) and a posterior non-banded zone (laid down throughout life). Has regenerative potential. Serves as basement membrane for endothelium. |
| 5. Endothelium | Single monolayer of polygonal cells. Maintains corneal deturgescence by active fluid pumping. Young adult density ~3,000 cells/mm². Declines ~0.6%/year; at <500 cells/mm², corneal oedema develops. Cannot regenerate. |
Dua's Layer: A recently proposed 6th layer (15 μm thick, between stroma and Descemet's membrane), though its distinctness is still debated.
— Kanski's Clinical Ophthalmology, 10th ed.; Histology: A Text and Atlas (Wojciech Pawlina)
Corneal Ulcer
Definition
A corneal ulcer is a serious infection involving multiple layers of the cornea — it develops secondary to breaks in the epithelial barrier, allowing infectious agents to invade the underlying corneal stroma.
Aetiology / Causative Organisms
| Category | Organisms |
|---|
| Bacteria | Pseudomonas aeruginosa (contact lens wearers), S. pneumoniae, S. aureus, Moraxella spp., Streptococcus |
| Viruses | Herpes simplex virus (HSV), Varicella zoster virus |
| Fungi | Candida, Aspergillus, Penicillium, Cephalosporium (Acremonium) |
| Protozoa | Acanthamoeba (contact lens wearers, water exposure) |
Predisposing factors: contact lens wear (especially extended-wear/overnight), corneal trauma, previous ocular surgery, immunosuppression, Bell's palsy/exposure keratitis, topical steroid use.
Clinical Features
Symptoms
- Red eye with conjunctival/ciliary injection
- Moderate-to-severe ocular pain / foreign body sensation
- Photophobia (consensual photophobia due to ciliary spasm from associated iritis)
- Decreased visual acuity (if ulcer is in visual axis or significant uveal inflammation)
- Mucopurulent discharge
- Acute contact lens intolerance
Signs
| Feature | Description |
|---|
| Corneal infiltrate | Round/irregular white, hazy stromal opacity with heaped-up edges |
| Epithelial defect | Stains with fluorescein; loss of epithelium overlying infiltrate |
| Stromal thinning | Tissue loss in stroma; slit beam cannot see through infiltrate to iris |
| Anterior chamber reaction | Flare and cells; hypopyon (sterile or infected) in severe cases |
| Miotic pupil | Due to iritis/ciliary spasm |
| Lid/conjunctival changes | Erythema, oedema, mucopurulent discharge |
Organism-specific features:
- Staphylococcal: well-defined, grey-white stromal infiltrate → dense stromal abscess
- Streptococcal: fulminant with severe hypopyon, or crystalline (in chronic steroid users)
- Pseudomonas: rapidly progressive, suppurative, necrotic infiltrate + hypopyon + mucopurulent discharge; can cause corneal melting and perforation
- Moraxella: indolent, inferior cornea, full-thickness, immunocompromised host
- Fungal: feathery borders, satellite lesions; history of vegetable/plant trauma
- Acanthamoeba: extreme pain, perineural invasion, ring infiltrate in late stages; swimming/contact lens history
Investigations
-
History: Contact lens type and care, water exposure, trauma, prior surgery, systemic illness, steroid/immunosuppressant use
-
Slit lamp examination:
- Fluorescein staining to map epithelial defect
- Document size, depth, and location of infiltrate
- Assess anterior chamber reaction (flare, cells, hypopyon size)
- Measure IOP (Tono-Pen preferred)
-
Corneal scrapings (culture if infiltrate >1–2 mm, in visual axis, unresponsive to treatment, or unusual organism suspected):
- Gram stain — bacteria
- Giemsa stain — Acanthamoeba cysts, fungi
- KOH preparation / Calcofluor white — fungi, Acanthamoeba
- Culture media: Blood agar, chocolate agar, Sabouraud's (fungi), non-nutrient agar with E. coli lawn (Acanthamoeba), Löwenstein-Jensen (atypical mycobacteria — keep 8 weeks)
-
Contact lens and case cultures (in contact lens wearers)
-
Confocal microscopy: For detecting Acanthamoeba cysts in vivo
The diagnosis is primarily clinical; cultures confirm the organism and guide targeted therapy.
Management
General Principles
- Treat empirically as bacterial until proven otherwise
- Initial therapy must be broad-spectrum
- Do NOT patch the eye (increases risk of Pseudomonas infection → corneal melting and perforation)
- Refer to ophthalmologist within 12–24 hours
Step-by-Step Treatment
1. Cycloplegia
- Cyclopentolate 1% t.i.d. — relieves ciliary spasm, prevents posterior synechiae
- Atropine 1% b.i.d.–t.i.d. if hypopyon is present
2. Topical Antibiotics (risk-stratified)
| Risk Level | Criteria | Treatment |
|---|
| Low risk | Small peripheral infiltrate, no/minimal AC reaction | Fluoroquinolone (moxifloxacin, gatifloxacin, ciprofloxacin) q1–2h while awake; or polymyxin B/trimethoprim |
| Borderline risk | 1–1.5 mm peripheral, or any with epithelial defect/mild AC reaction | Fluoroquinolone q1h around the clock ± polymyxin B/trimethoprim q1h. Loading: 1 drop q5 min × 5 doses → q30 min → q1h |
| Vision-threatening | >1.5–2 mm, in visual axis, or unresponsive to initial Rx | Fortified antibiotics: Fortified tobramycin/gentamicin (15 mg/mL) q1h alternating with fortified cefazolin (50 mg/mL) q1h (drop every 30 min around the clock). If MRSA suspected: substitute vancomycin (25 mg/mL). If Pseudomonas suspected: add fortified ceftazidime q1h |
3. Specific Infections
- Fungal: Natamycin 5% (filamentous), amphotericin B (Candida), voriconazole; consider intrastromal antifungal injections (ophthalmologist)
- HSV: Topical acyclovir/ganciclovir; systemic acyclovir for stromal disease
- Acanthamoeba: PHMB (polyhexamethylene biguanide) + propamidine (Brolene) for several months
- Bacterial coinfection may complicate fungal/Acanthamoeba keratitis — broaden accordingly
4. Adjunctive Measures
- Topical steroids: Relatively contraindicated in viral infections; may reduce scarring/perforation risk in bacterial keratitis but only under ophthalmologist guidance; never initiate in the ED without ophthalmology advice
- Corneal thinning: Protect with a shield (no patch). Add doxycycline 100 mg p.o. b.i.d. (MMP inhibitor) + vitamin C (collagen synthesis promoter)
- IOP management: If raised, topical β-blocker or carbonic anhydrase inhibitor (avoid prostaglandins)
Surgical Management
| Indication | Procedure |
|---|
| Non-healing/refractory ulcer | Therapeutic penetrating keratoplasty (PKP) |
| Impending perforation | Tissue adhesive (cyanoacrylate), amniotic membrane graft, or emergency PKP |
| Corneal perforation | Emergency PKP or patch graft |
Complications
- Corneal scarring → permanent visual impairment
- Corneal perforation → endophthalmitis
- Anterior and posterior synechiae
- Secondary glaucoma
- Cataract
- Phthisis bulbi (end-stage)
Sources: Tintinalli's Emergency Medicine (9th ed.); The Wills Eye Manual (7th ed.); Kanski's Clinical Ophthalmology (10th ed.)